Our novel droplet technology provides enhanced bio-availability for both anterior and posterior segments of the eye. High solubility capacity transcends traditional limitations of size and polarity. the ability to achieve higher concentrations of known APIs enables treatment of severe cases, Improved safety and efficacy,reduced treatment burden, and targeted delivery capability enables topical treatment for posterior segment diseases like age related macular degeneration.
Company Details
- Founded
- 2016
- Address
- Kiryat Atidim, Building 7,entrance 1,2nd Floor,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Ophthalmology, Drug Delivery Platform, Biotechnology, Nano Droplets, Molecular Architecture.
- HQ
- Tel Aviv
Ophrx Questions
Ophrx's website is https://bio-light.co.il/ophrx-noninvasive-topical-drug-delivery-technology/
Ophrx's LinkedIn profile is https://il.linkedin.com/company/ophrx
Ophrx's industry is
Biotechnology Research
Ophrx's top competitors are
Emmecell,
Genufeed,
Se-Cure Pharmaceuticals Ltd.,
Vaxil Bio Ltd.,
Meir Science Technologies Ltd.,
Peripherex,
Nanorobotics,
Tavo Biotherapeutics,
Clal Biotechnology Industries.
Ophrx's categories are Biotechnology Research
Ophrx's founding year is 2016
